| Total zinc intake |  | ||||
 | Q1 | Q2 | Q3 | Q4 | Q5 | P trend |
Number of subjects (T2D cases) | 5234 (638) | 5228 (719) | 5223 (789) | 5221 (832) | 5226 (698) | Â |
Person-years | 88,923 | 91,333 | 90,929 | 91,301 | 93,281 | Â |
Model 1 | 1.00 (ref) | 1.10 (0.99–1.23) | 1.22 (1.10–1.35) | 1.29 (1.16–1.43) | 1.07 (0.96–1.19) | 0.017 |
Model 2 | 1.00 (ref) | 1.14 (1.00–1.29) | 1.19 (1.06–1.35) | 1.25 (1.11–1.41) | 1.14 (1.01–1.29) | 0.011 |
Model 3 | 1.00 (ref) | 1.17 (1.03–1.32) | 1.23 (1.08–1.39) | 1.29 (1.14–1.47) | 1.16 (1.02–1.32) | 0.008 |
Model 4 | 1.00 (ref) | 1.09 (0.92–1.29) | 1.11 (0.94–1.32) | 1.26 (1.06–1.49) | 1.05 (0.88–1.25) | 0.212 |
 | Dietary zinc intake |  | ||||
 | Q1 | Q2 | Q3 | Q4 | Q5 | P trend |
Number of subjects (T2D cases) | 5234 (617) | 5231 (674) | 5224 (705) | 5219 (808) | 5224 (872) | Â |
Person-years | 89,374 | 91,085 | 91,528 | 92,067 | 91,714 | Â |
Model 1 | 1.00 (ref) | 1.08 (0.97–1.20) | 1.14 (1.02–1.27) | 1.31 (1.18–1.46) | 1.43 (1.29–1.58) | < 0.0001 |
Model 2 | 1.00 (ref) | 1.10 (0.97–1.25) | 1.15 (1.01–1.30) | 1.25 (1.11–1.42) | 1.31 (1.16–1.48) | < 0.0001 |
Model 3 | 1.00 (ref) | 1.14 (1.00–1.29) | 1.19 (1.05–1.35) | 1.32 (1.16–1.49) | 1.39 (1.22–1.57) | < 0.0001 |
Model 4 | 1.00 (ref) | 1.05 (0.89–1.25) | 1.12 (0.94–1.32) | 1.26 (1.06–1.49) | 1.27 (1.06–1.51) | 0.001 |
 | Zinc to iron ratio |  | ||||
 | Q1 | Q2 | Q3 | Q4 | Q5 | P trend |
Number of subjects (T2D cases) | 5223 (782) | 5227 (801) | 5225 (740) | 5228 (656) | 5229 (697) | Â |
Person-years | 90,860 | 90,977 | 90,965 | 91,825 | 91,141 | Â |
Model 1 | 1.00 (ref) | 1.06 (0.96–1.17) | 0.98 (0.89–1.08) | 0.86 (0.77–0.95) | 0.90 (0.81–1.00) | < 0.0001 |
Model 2 | 1.00 (ref) | 1.02 (0.91–1.14) | 0.92 (0.82–1.03) | 0.91 (0.81–1.03) | 0.91 (0.81–1.02) | 0.027 |
Model 3 | 1.00 (ref) | 1.01 (0.90–1.14) | 0.91 (0.82–1.03) | 0.90 (0.80–1.02) | 0.91 (0.81–1.02) | 0.023 |
Model 4 | 1.00 (ref) | 1.02 (0.87–1.20) | 0.96 (0.82–1.13) | 0.92 (0.78–1.08) | 0.91 (0.77–1.07) | 0.110 |
 | Zinc supplement use |  |  |  |  | |
 | No | Yes |  |  |  |  |
Number of subjects (T2D cases) | 21,715 (3225) | 4417 (451) | Â | Â | Â | Â |
Person-years | 376,020 | 79,748 | Â | Â | Â | Â |
Model 1 | 1.00 (ref) | 0.68 (0.62–0.75) |  |  |  |  |
Model 2 | 1.00 (ref) | 0.83 (0.74–0.92) |  |  |  |  |
Model 3 | 1.00 (ref) | 0.79 (0.70–0.89) |  |  |  |  |
Model 4 | 1.00 (ref) | 0.83 (0.71–0.98) |  |  |  |  |